Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: A case report and review of literature

Diagnostic Pathology

Volumn 7, Issue 1, 2012, Pages

  Yang, Qing Xu ^a   Pei, Xiao Juan ^a,b   Tian, Xiao Ying ^c   Li, Yang ^b   Li, Zhi ^b  

^a HUIZHOU MUNICIPAL CENTRAL HOSPITAL   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Angioimmunoblastic T cell lymphoma; Epstein barr virus; Secondary B cell lymphoma; Skin lesion

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; MONOCLONAL ANTIBODY; PREDNISONE; RITUXIMAB; TUMOR MARKER; VINCRISTINE; VIRUS DNA;

AGED; BIOPSY; CASE REPORT; EPSTEIN BARR VIRUS; GENETICS; HUMAN; IMMUNOBLASTIC LYMPHADENOPATHY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IN SITU HYBRIDIZATION; ISOLATION AND PURIFICATION; LARGE CELL LYMPHOMA; LYMPH NODE; MALE; PATHOLOGY; REVIEW; SECOND CANCER; SKIN TUMOR; T CELL LYMPHOMA; TREATMENT OUTCOME; VIROLOGY;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CYCLOPHOSPHAMIDE; DNA, VIRAL; DOXORUBICIN; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODES; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, T-CELL; MALE; NEOPLASMS, SECOND PRIMARY; PREDNISONE; SKIN NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VINCRISTINE;

EID: 84862818028     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-7-7     Document Type: Article

References (24)

1. Rüdiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA, Nathwani BN, Ullrich F, Müller-Hermelink HK, . Non-Hodgkin's Lymphoma Classification Project Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 2002, 13:140-149. 10.1093/annonc/mdf033, 11863096, Non-Hodgkin's Lymphoma Classification Project.
2. Dogan A, Attygalle AD, Kyriakou C. Angioimmunoblastic T-cell lymphoma. Br J Haematol 2003, 121:681-691. 10.1046/j.1365-2141.2003.04335.x, 12780782.
3. Dogan A, Gaulard P, Jaffe ES, Ralfkiaer E, Müller-Hermelink HK. Angioimmunoblastic T-cell lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, 309-311. Lyon: IARC, Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, 4.
4. Abruzzo LV, Schmidt K, Weiss LM, Jaffe ES, Medeiros LJ, Sander CA, Raffeld M. B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus. Blood 1993, 82:241-246.
5. Park S, Noguera ME, Brière J, Feuillard J, Cayuela JM, Sigaux F, Brice P. Successful rituximab treatment of an EBV-related lymphoproliferative disease arising after autologous transplantation for angioimmunoblastic T-cell lymphoma. Hematol J 2002, 3:317-720. 10.1038/sj.thj.6200202, 12522456.
6. Xu Y, McKenna RW, Hoang MP, Collins RH, Kroft SH. Composite angioimmunoblastic T-cell lymphoma and diffuse large B-cell lymphoma: a case report and review of the literature. Am J Clin Pathol 2002, 118:848-854. 10.1309/VD2D-98ME-MB3F-WH34, 12472277.
7. Zettl A, Lee SS, Rüdiger T, Starostik P, Marino M, Kirchner T, Ott M, Müller-Hermelink HK, Ott G. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol 2002, 117:368-379. 10.1309/6UTX-GVC0-12ND-JJEU, 11888076.
8. Hawley RC, Cankovic M, Zarbo RJ. Angioimmunoblastic T-cell lymphoma with supervening Epstein-Barr virus-associated large B-cell lymphoma. Arch Pathol Lab Med 2006, 130:1707-1711.
9. Attygalle AD, Kyriakou C, Dupuis J, Grogg KL, Diss TC, Wotherspoon AC, Chuang SS, Cabeçadas J, Isaacson PG, Du MQ, Gaulard P, Dogan A. Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression. Am J Surg Pathol 2007, 31:1077-1088. 10.1097/PAS.0b013e31802d68e9, 17592275.
10. Willenbrock K, Bräuninger A, Hansmann ML. Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases. Br J Haematol 2007, 138:733-739. 10.1111/j.1365-2141.2007.06725.x, 17672882.
11. Weisel KC, Weidmann E, Anagnostopoulos I, Kanz L, Pezzutto A, Subklewe M. Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma. Int J Hematol 2008, 88:434-440. 10.1007/s12185-008-0176-2, 18839273.
12. Takahashi T, Maruyama R, Mishima S, Inoue M, Kawakami K, Onishi C, Miyake T, Tanaka J, Nabika T, Ishikura H. Small bowel perforation caused by Epstein-Barr virus-associated B cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma. J Clin Exp Hematop 2010, 50:59-63. 10.3960/jslrt.50.59, 20505277.
13. Skugor ND, Perić Z, Vrhovac R, Radić-Kristo D, Kardum-Skelin I, Jaksić B. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma. Coll Antropol 2010, 34:241-245.
14. Huang J, Zhang PH, Gao YH, Qiu LG. Sequential development of diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma. Diagn Cytopathol 2011, doi:10.1002/dc.21641.
15. Frizzera G, Moran EM, Rappaport H. Angioimmunoblastic lymphadenopathy with dysproteinaemia. Lancet 1974, 1:1070-1073.
16. Frizzera G, Moran EM, Rappaport H. Angio-immunoblastic lymphadenopathy: diagnosis and clinical course. Am J Med 1975, 59:803-818. 10.1016/0002-9343(75)90466-0, 1190254.
17. O'Connor NT, Crick JA, Wainscoat JS, Gatter KC, Stein H, Falini B, Mason DY. Evidence for monoclonal T lymphocyte proliferation in angioimmunoblastic lymphadenopathy. J Clin Pathol 1986, 39:1229-1232. 10.1136/jcp.39.11.1229, 1140768, 3491840.
18. Feller AC, Griesser H, Schilling CV, Wacker HH, Dallenbach F, Bartels H, Kuse R, Mak TW, Lennert K. Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy. Am J Pathol 1988, 133:549-556. 1880823, 2849301.
19. Smith JL, Hodges E, Quin CT, McCarthy KP, Wright DH. Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy. Am J Pathol 2000, 156:661-669. 10.1016/S0002-9440(10)64770-0, 1850038, 10666395.
20. Frizzera G, Kaneko Y, Sakurai M. Angioimmunoblastic lymphadenopathy and related disorders: a retrospective look in search of definitions. Leukemia 1989, 3:1-5.
21. de Leval L, Rickman DS, Thielen C, Reynies A, Huang YL, Delsol G, Lamant L, Leroy K, Brière J, Molina T, Berger F, Gisselbrecht C, Xerri L, Gaulard P. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 2007, 109:4952-4963. 10.1182/blood-2006-10-055145, 17284527.
22. Attygalle A, Al-Jehani R, Diss TC, Munson P, Liu H, Du MQ, Isaacson PG, Dogan A. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002, 99:627-633. 10.1182/blood.V99.2.627, 11781247.
23. Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 2006, 30:802-810. 10.1097/01.pas.0000209855.28282.ce, 3137919, 16819321.
24. Weiss LM, Jaffe ES, Liu XF, Chen YY, Shibata D, Medeiros LJ. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 1992, 79:1789-1795.